Log in or Sign up for Free to view tailored content for your specialty!
Vaccination
Study: Three-quarters of infants protected against RSV last season
Nearly 80% of infants born in a California health system were exposed to nirsevimab or the maternal respiratory syncytial virus vaccine in 2023-2024, the first season in which they were available, according to study findings.
Study: Apnea more common among preterm infants who receive 2-month vaccines
Short-term apnea is more common among hospitalized preterm infants who receive their 2-month vaccines compared with those who do not, according to the results of a randomized clinical trial published in JAMA Pediatrics.
Q&A: Cause of DRC outbreak identified as combination of malaria, flu and malnutrition
In early December, health officials in the Democratic Republic of the Congo, or DRC, announced that an unknown illness had emerged and had already killed dozens of patients, with hundreds more sick.
Log in or Sign up for Free to view tailored content for your specialty!
WHO: 8 dead in suspected Marburg outbreak in Tanzania
A suspected Marburg virus outbreak in Tanzania has been linked to nine cases and eight deaths, according to WHO.
Study: 1 in 6 US children have received vaccine dose at incorrect time
Nearly one in six U.S. children received at least one vaccine dose outside the recommended age guidelines during a recent 10-year period, according to study findings published in Pediatrics.
2024 brought more troubling news about measles
A surge in measles cases linked to declining vaccination rates could threaten the United States’ measles elimination status, the CDC said in 2024.
An app to diagnose ear infections? Our top questions for pediatricians in 2024
The most-read Healio Pediatrics story of 2024 was a Q&A with Lisa L. Abuogi, MD, MSc, FAAP, who co-authored the AAP’s policy statement in support of breastfeeding for parents with HIV.
‘We have to be worried’: Top pediatric vaccine news of 2024
Routine childhood immunizations have prevented 1.1 million deaths in the United States since the CDC’s Vaccines for Children program launched in 1994, according to researchers.
FDA accepts biologics license application for Merck’s RSV shot
The FDA accepted a biologics license application for Merck’s respiratory syncytial virus immunization, clesrovimab, the company announced Tuesday.
FDA committee asks for more data on RSV vaccine safety in infants
An FDA advisory committee said it wants to see more data to understand the implications of what the FDA called an “imbalance” in cases of severe respiratory syncytial virus among infants participating in an early-stage RSV vaccine trial.
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read
-
Headline News
Medicare selects 15 drugs for second round of price negotiations, including semaglutide
January 17, 20252 min read -
Headline News
Q&A: Physicians can help patients with respiratory diseases prepare for wildfires
January 17, 20253 min read -
Headline News
‘Now is not the time to lose momentum’ in the fight against STIs
January 10, 20259 min read